Michelle Kelleher

1.3k total citations
18 papers, 578 citations indexed

About

Michelle Kelleher is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Michelle Kelleher has authored 18 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Michelle Kelleher's work include Virus-based gene therapy research (6 papers), Retinal Diseases and Treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). Michelle Kelleher is often cited by papers focused on Virus-based gene therapy research (6 papers), Retinal Diseases and Treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). Michelle Kelleher collaborates with scholars based in United Kingdom, United States and Australia. Michelle Kelleher's co-authors include Kyriacos Mitrophanous, Richard Harrop, Scott Ellis, Stuart Naylor, Fiona M. Tomley, Peter C. L. Beverley, Tahreem A. Mir, Matthew C. Anderton, Elliott H. Sohn and Andreas Lauer and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Investigative Ophthalmology & Visual Science.

In The Last Decade

Michelle Kelleher

17 papers receiving 564 citations

Peers

Countries citing papers authored by Michelle Kelleher

Since Specialization

Citations

This map shows the geographic impact of Michelle Kelleher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Kelleher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Kelleher more than expected).

Fields of papers citing papers by Michelle Kelleher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Kelleher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Kelleher. The network helps show where Michelle Kelleher may publish in the future.

Co-authorship network of co-authors of Michelle Kelleher

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Kelleher. A scholar is included among the top collaborators of Michelle Kelleher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Kelleher. Michelle Kelleher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Gene Therapy for Parkinson’s Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis 2019 ·Molecular Therapy — Methods & Clinical Development ·Romina Aron Badin, Katie Binley, Nadja Van Camp, Caroline Jan, (unknown), (unknown), Pauline Gipchtein, (unknown), Hannah J. Stewart, G. Ralph, Yatish Lad, Michelle Kelleher, Julie Loader, Koichi Hosomi, Stéphane Palfi, Kyriacos Mitrophanous, Philippe Hantraye	19
2	Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant Patients 2018 ·Human Gene Therapy ·(unknown), Maria A. Parker, (unknown), Katie Binley, (unknown), Julie Loader, Michelle Kelleher, Kyriacos Mitrophanous, J. Timothy Stout, Scott Ellis	10
3	Phase I Safety and Tolerability results for RetinoStat®, a Lentiviral Vector Expressing Endostatin and Angiostatin, in Patients with Advanced Neovascular Age-Related Macular Degeneration 2016 ·Investigative Ophthalmology & Visual Science ·Andreas Lauer, Peter A. Campochiaro, Elliott H. Sohn, Michelle Kelleher, Richard Harrop, Julie Loader, Scott Ellis, Kyriacos Mitrophanous	1
4	Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study 2016 ·Human Gene Therapy ·Peter A. Campochiaro, Andreas Lauer, Elliott H. Sohn, Tahreem A. Mir, Stuart Naylor, Matthew C. Anderton, Michelle Kelleher, Richard Harrop, Scott Ellis, Kyriacos Mitrophanous	151
5	200. Advancing a State of the Art Gene Therapy for Parkinson's Disease 2015 ·Molecular Therapy ·Romina Aron Badin, Katie Binley, Nadja Van Camp, Caroline Jan, (unknown), Hannah J. Stewart, (unknown), Yatish Lad, Michelle Kelleher, Julie Loader, Koichi Hosomi, Stéphane Palfi, (unknown), Kyriacos Mitrophanous	0
6	Results from the Phase I GEM study, evaluating safety and tolerability of subretinally-injected lentiviral vector (RetinoStat®) for the treatment of wet age-related macular degeneration (AMD) 2015 ·Simon Chandler, Peter A. Campochiaro, Andreas Lauer, Elliott H. Sohn, (unknown), Michelle Kelleher, Richard Harrop, Scott Ellis, Kyriacos Mitrophanous	1
7	EIAV-Based Retinal Gene Therapy in the shaker1 Mouse Model for Usher Syndrome Type 1B: Development of UshStat 2014 ·PLoS ONE ·Marisa Zallocchi, Katie Binley, Yatish Lad, Scott Ellis, Peter Widdowson, Sharifah Iqball, (unknown), Michelle Kelleher, Julie Loader, James Miskin, (unknown), (unknown), Linda Cheung, Duane Delimont, Kyriacos Mitrophanous, Dominic Cosgrove	83
8	Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax) 2012 ·Cancer Immunology Immunotherapy ·Richard Harrop, Peter Treasure, Jackie de Belin, Michelle Kelleher, (unknown), Stuart Naylor, William Shingler	19
9	Safety and Biodistribution of an Equine Infectious Anemia Virus-Based Gene Therapy, RetinoStat ^® , for Age-Related Macular Degeneration 2012 ·Human Gene Therapy ·Katie Binley, Peter Widdowson, Michelle Kelleher, Jackie de Belin, Julie Loader, (unknown), (unknown), (unknown), (unknown), (unknown), Scott Ellis, Kyriacos Mitrophanous, James Miskin, (unknown), T. Michael Nork, P. Elliott Miller, Stuart Naylor	48
10	MVA–5T4-induced immune responses are an early marker of efficacy in renal cancer patients 2011 ·Cancer Immunology Immunotherapy ·Richard Harrop, William Shingler, (unknown), Peter Treasure, Robert J. Amato, Robert E. Hawkins, Howard L. Kaufman, Jackie de Belin, Michelle Kelleher, (unknown), Stuart Naylor	22
11	Cross-trial Analysis of Immunologic and Clinical Data Resulting From Phase I and II Trials of MVA-5T4 (TroVax) in Colorectal, Renal, and Prostate Cancer Patients 2010 ·Journal of Immunotherapy ·Richard Harrop, William Shingler, Michelle Kelleher, Jackie de Belin, Peter Treasure	28
12	A Stable Producer Cell Line for the Manufacture of a Lentiviral Vector for Gene Therapy of Parkinson's Disease 2010 ·Human Gene Therapy ·Hannah J. Stewart, (unknown), Iain Strickland, (unknown), Michelle Kelleher, Laura Stevenson, Vinay Thoree, (unknown), G. Ralph, Kyriacos Mitrophanous, Pippa A. Radcliffe	27
13	Water and Watersheds Research: Discovery and Broader Impacts 2007 ·Journal of Contemporary Water Research & Education ·Penelope L. Firth, Michelle Kelleher, Barbara Levinson	1
14	Vaccination Against the Tumour Associated Antigen 5T4 Induces Immune Responses in Advanced Colorectal Cancer Patients: Results Phase I/II Clinical Trial with Recombinant Modified Vaccinia Virus Ankara(TroVax) 2004 ·Journal of Immunotherapy ·Robert D. Hawkins, (unknown), Richard Harrop, Irina Redchenko, Matthew G. Ryan, Noel Drury, Michelle Kelleher, (unknown), Miles W. Carroll	1
15	Lipopolysaccharide Modulation of Dendritic Cells Is Insufficient to Mature Dendritic Cells to Generate CTLs from Naive Polyclonal CD8+ T Cells In Vitro, Whereas CD40 Ligation Is Essential 2001 ·The Journal of Immunology ·Michelle Kelleher, Peter C. L. Beverley	39
16	Transient expression of β-galactosidase in differentiating sporozoites of Eimeria tenella 1998 ·Molecular and Biochemical Parasitology ·Michelle Kelleher, Fiona M. Tomley	45
17	Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes 1994 ·Molecular and Biochemical Parasitology ·Michelle Kelleher, Joan Curtis, David L. Sacks, Emanuela Handman, Antony Bacic	29
18	Lipophosphoglycan expression and virulence in Ricin-resistant variants of Leishmania major 1990 ·Molecular and Biochemical Parasitology ·Martin J. Elhay, Michelle Kelleher, Antony Bacic, Malcolm J. McConville, Douglas L. Tolson, Terry W. Pearson, Emanuela Handman	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact